We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Medicare Part D Spending on Single-Enantiomer Drugs Versus Their Racemic Precursors.
- Authors
Egilman, Alexander C.; Zhang, Audrey D.; Wallach, Joshua D.; Ross, Joseph S.
- Abstract
The article aims to estimate the potential savings associated with using racemic precursors instead of their singleenantiomer versions to the Medicare Part D drug benefit program and its beneficiaries. It mentions that the adopting name prefixes assigned to drugs with a single-enantiomer formulation to identify all new, single-enantiomer drugs originating from a racemic precursor previously approved by the U.S. Food & Drug Administration.
- Subjects
MEDICARE Part D; DRUGS
- Publication
Annals of Internal Medicine, 2019, Vol 171, Issue 7, p521
- ISSN
0003-4819
- Publication type
journal article
- DOI
10.7326/M19-1085